Flora Growth Corp. Supports Germany's Cannabis Model City Initiative, Pioneering Controlled THC Retail in Frankfurt and Hannover
Flora Growth Corp. (NASDAQ: FLGC) has announced its support for Germany's pioneering cannabis model city projects in Frankfurt and Hannover, set to launch in early 2025. These initiatives represent Germany's first controlled cannabis retail efforts, allowing both cities to gather data on consumption behaviors and public health impacts.
The projects will establish authorized sales locations for THC products, including cannabis flowers and hashish, available only to registered adult residents. Participants will undergo regular health assessments during the five-year study period. The initiative aims to combat illegal cannabis markets and inform future regulations across Europe.
Flora Growth Corp. (NASDAQ: FLGC) ha annunciato il suo sostegno ai progetti pionieristici di città modello per la cannabis in Francoforte e Hannover, che dovrebbero lanciarsi all'inizio del 2025. Queste iniziative rappresentano i primi sforzi di vendita controllata di cannabis in Germania, consentendo a entrambe le città di raccogliere dati sui comportamenti di consumo e sugli impatti sulla salute pubblica.
I progetti stabiliranno luoghi di vendita autorizzati per prodotti contenenti THC, inclusi fiori di cannabis e hashish, disponibili solo per i residenti adulti registrati. I partecipanti saranno sottoposti a valutazioni della salute regolari durante il periodo di studio di cinque anni. L'iniziativa mira a combattere i mercati illegali della cannabis e a informare le future regolamentazioni in tutta Europa.
Flora Growth Corp. (NASDAQ: FLGC) ha anunciado su apoyo a los proyectos de ciudades modelo de cannabis pioneros de Alemania en Fráncfort y Hannover, que se lanzarán a principios de 2025. Estas iniciativas representan los primeros esfuerzos de venta controlada de cannabis en Alemania, permitiendo a ambas ciudades recopilar datos sobre los comportamientos de consumo y los impactos en la salud pública.
Los proyectos establecerán lugares de venta autorizados para productos de THC, incluyendo flores de cannabis y hachís, disponibles solo para residentes adultos registrados. Los participantes serán sometidos a evaluaciones de salud regulares durante el período de estudio de cinco años. La iniciativa tiene como objetivo combatir los mercados ilegales de cannabis e informar futuras regulaciones en toda Europa.
Flora Growth Corp. (NASDAQ: FLGC)는 프랑크푸르트와 하노버에서 2025년 초에 시작될 독일의 선도적인 대마초 모델 도시 프로젝트에 대한 지원을 발표했습니다. 이러한 이니셔티브는 독일의 첫 번째 통제된 대마초 소매 노력으로, 두 도시가 소비 행동 및 공공 건강에 미치는 영향을 조사할 수 있도록 합니다.
이 프로젝트는 THC 제품, 즉 대마초 꽃과 해시쉬의 판매를 위해 허가된 판매 장소를 설정하며, 이러한 제품은 등록된 성인 거주자만 이용할 수 있습니다. 참가자들은 5년 연구 기간 동안 정기적인 건강 평가를 받습니다. 이 이니셔티브는 불법 대마초 시장을 근절하고 향후 유럽 전역의 규정을 안내하는 것을 목표로 합니다.
Flora Growth Corp. (NASDAQ: FLGC) a annoncé son soutien aux projets de villes modèles pionniers pour le cannabis en Francfort et Hanovre, qui devraient être lancés début 2025. Ces initiatives représentent les premiers efforts de vente de cannabis contrôlés en Allemagne, permettant aux deux villes de recueillir des données sur les comportements de consommation et les impacts sur la santé publique.
Les projets établiront des lieux de vente autorisés pour les produits contenant du THC, y compris des fleurs de cannabis et du haschich, disponibles uniquement pour les résidents adultes enregistrés. Les participants seront soumis à des évaluations de santé régulières pendant la période d'étude de cinq ans. L'initiative vise à lutter contre les marchés illégaux du cannabis et à informer les futures réglementations à travers l'Europe.
Flora Growth Corp. (NASDAQ: FLGC) hat seine Unterstützung für Deutschlands wegweisende Modellstadtprojekte für Cannabis in Frankfurt und Hannover angekündigt, die Anfang 2025 starten sollen. Diese Initiativen stellen Deutschlands erste kontrollierten Verkaufsbemühungen für Cannabis dar und ermöglichen es beiden Städten, Daten zu Konsumverhalten und Auswirkungen auf die öffentliche Gesundheit zu sammeln.
Die Projekte werden autorisierte Verkaufsstellen für THC-Produkte, einschließlich Cannabisblüten und Haschisch, einrichten, die nur für registrierte erwachsene Bewohner erhältlich sind. Teilnehmer werden während des fünfjährigen Studienzeitraums regelmäßigen Gesundheitsbewertungen unterzogen. Die Initiative zielt darauf ab, illegale Cannabis-Märkte zu bekämpfen und zukünftige Regulierungen in ganz Europa zu informieren.
- Strategic positioning in Germany's emerging legal cannabis market
- Early involvement in pioneering regulated cannabis retail projects
- Potential for market expansion in European cannabis sector
- Project implementation delayed until 2025
- to registered residents only, restricting market size
- Strict regulatory requirements may impact operational flexibility
Insights
Germany's model city initiative represents a significant market research opportunity but immediate business impact for Flora Growth. While the company expresses support, there's no concrete financial commitment or direct participation announced. The pilot programs in Frankfurt and Hannover, launching in 2025, will be highly controlled with restricted participation, suggesting minimal near-term revenue potential.
The five-year study timeframe indicates a long-term strategic play rather than immediate market access. For a company with
Fort Lauderdale, Florida--(Newsfile Corp. - October 31, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today announced its strong support for Germany's historic cannabis model city projects in Frankfurt and Hannover. These initiatives, marking Germany's first controlled cannabis retail efforts, will allow the cities to gather valuable insights on consumption behaviors, public health, and strategies to combat the illegal cannabis market, moving the country's cannabis policy from theory to practice.
Scheduled to launch in early 2025, the model city projects were established to support scientific research into cannabis consumption under regulated, controlled conditions. In Hannover, the initiative-championed by Mayor Belit Onay-will involve up to three authorized sales locations for THC products, including cannabis flowers and hashish, available to registered adult participants only.
Similarly, Frankfurt will implement a controlled cannabis distribution system led by Social and Health Officer Elke Voitl, who has structured the project to ensure purchases are restricted to healthy adult residents registered within the city's dedicated cannabis shops. As part of the five-year study, participants in both cities will undergo regular health assessments to measure any impact on their health and well-being.
"We commend Germany's progressive approach in advancing cannabis regulation through these model projects," stated Clifford Starke, Chief Executive Officer. "The transition from a theoretical framework to an applied model in controlled retail represents an extraordinary opportunity for robust public health research. This effort aligns with Flora's vision to provide safe, effective cannabis products under the highest standards of regulatory compliance and to enhance consumer understanding of cannabis in Europe."
Mr. Starke continued, "Flora is particularly motivated by the role that Hannover and Frankfurt will play as trailblazers in Europe, helping shape the future of responsible cannabis retail on the continent. These controlled studies are critical steps in informing future regulations across Europe, and Flora is proud to contribute our capabilities and insights to support Germany in this endeavor."
The introduction of these controlled retail models represents an important milestone in Europe's cannabis industry and underscores Germany's commitment to pursuing evidence-based cannabis policy. Flora looks forward to being part of this transformative journey as the German government seeks to build a safer, transparent, and well-regulated cannabis market for its citizens.
About Flora Growth Corp.
Flora Growth Corp.'s mission is to become the leading NASDAQ small-cap international cannabis company. Flora is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228420
FAQ
When will Flora Growth Corp. (FLGC) begin operations in Germany's model city projects?
What products will be available through FLGC in the German model cities?
How long will the FLGC-supported German cannabis model city study last?
Which German cities are participating in the cannabis model city initiative supported by FLGC?
